Published in Invest Ophthalmol Vis Sci on May 01, 1999
Effect of inflammation on lacrimal gland function. Exp Eye Res (2005) 1.68
Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf (2009) 1.33
Sjögren's syndrome: an old tale with a new twist. Arch Immunol Ther Exp (Warsz) (2009) 1.16
Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci (2003) 1.09
Lipidomics of human Meibomian gland secretions: Chemistry, biophysics, and physiological role of Meibomian lipids. Prog Lipid Res (2011) 1.06
Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease. PLoS One (2014) 0.98
Conjunctival mucin deficiency in complete androgen insensitivity syndrome (CAIS). Graefes Arch Clin Exp Ophthalmol (2006) 0.85
[Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface. New concepts for understanding dry eye disease]. Ophthalmologe (2003) 0.85
Current status of gene delivery and gene therapy in lacrimal gland using viral vectors. Adv Drug Deliv Rev (2006) 0.82
The role of corneal afferent neurons in regulating tears under normal and dry eye conditions. Exp Eye Res (2013) 0.81
In situ fluorescence measurement of tear film [Na+], [K+], [Cl-], and pH in mice shows marked hypertonicity in aquaporin-5 deficiency. Invest Ophthalmol Vis Sci (2009) 0.81
Corneal sensitivity following lacrimal gland excision in the rat. Invest Ophthalmol Vis Sci (2015) 0.81
[Sex hormones and dry eye]. Ophthalmologe (2009) 0.78
Patients with blepharitis are at elevated risk of anxiety and depression. PLoS One (2013) 0.77
Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease. FASEB J (2016) 0.76
Effects of extract of Buddleja officinalis on partial inflammation of lacrimal gland in castrated rabbits with dry eye. Int J Ophthalmol (2010) 0.75
Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease. Ocul Immunol Inflamm (2014) 0.75
Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol (1996) 3.40
Hormone replacement therapy and dry eye syndrome. JAMA (2001) 2.46
The epidemic of Acanthamoeba keratitis: where do we stand? Cornea (1998) 1.98
A systematic overview of the incidence of posterior capsule opacification. Ophthalmology (1998) 1.98
Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today (1997) 1.83
Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol (2001) 1.74
Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol (1995) 1.73
The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci (2001) 1.71
Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology (1995) 1.64
Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand (2000) 1.61
Three different types of dry eye syndrome. Cornea (1994) 1.53
Practical double vital staining for ocular surface evaluation. Cornea (1993) 1.50
Proteomic analysis of human meibomian gland secretions. Br J Ophthalmol (2006) 1.42
Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med (1992) 1.42
Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab (2000) 1.33
Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation. J Immunol (2001) 1.32
Tear function index. A new measure of dry eye. Arch Ophthalmol (1995) 1.30
Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol (2000) 1.27
A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci (2001) 1.25
TNF-alpha regulates corneal Langerhans cell migration. J Immunol (1999) 1.24
Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocrinol Metab (2000) 1.17
Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci (2000) 1.15
Tissue Doppler-derived index of left ventricular filling pressure, E/E', predicts survival of patients with non-valvular atrial fibrillation. Heart (2006) 1.13
Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc (1999) 1.13
Corneal graft rejection is accompanied by apoptosis of the endothelium and is prevented by gene therapy with bcl-xL. Am J Transplant (2007) 1.12
Sex steroids, the meibomian gland and evaporative dry eye. Adv Exp Med Biol (2002) 1.12
Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J (1990) 1.10
Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sjögren's syndrome. Adv Exp Med Biol (2002) 1.02
Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome. Exp Eye Res (1999) 1.01
The complement system in ischemic heart disease. Circulation (1990) 1.01
Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. Invest Ophthalmol Vis Sci (1999) 1.00
Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval. Cardiovasc Res (1985) 1.00
Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. J Interferon Cytokine Res (1999) 0.98
Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch Ophthalmol (1998) 0.98
Sex steroids, meibomian gland dysfunction and evaporative dry eye in Sjögren's syndrome. Lupus (2002) 0.96
Predictors of occult scleral rupture. Ophthalmology (1994) 0.95
Corneal temperature in patients with dry eye evaluated by infrared radiation thermometry. Br J Ophthalmol (1996) 0.95
Effect of laser in situ keratomileusis correction on contrast visual acuity. J Cataract Refract Surg (2001) 0.94
Allergic conjunctivitis and dry eye. Br J Ophthalmol (1996) 0.92
Androgens and dry eye in Sjögren's syndrome. Ann N Y Acad Sci (1999) 0.92
Poor illumination, VDTs, and desiccated eyes. Lancet (1996) 0.91
Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol (1995) 0.91
Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions. Adv Exp Med Biol (2002) 0.91
Iatrogenic cataract after laser-assisted in situ keratomileusis. Am J Ophthalmol (1999) 0.90
Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis. Am J Ophthalmol (1997) 0.89
Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Invest Ophthalmol Vis Sci (2001) 0.89
High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol (1999) 0.89
ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants. Transplantation (2000) 0.89
Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury. Am Heart J (1994) 0.88
Visual rehabilitation in children with congenital hereditary endothelial dystrophy. Int Ophthalmol Clin (2001) 0.88
Nutrient intake in women with primary and secondary Sjögren's syndrome. Eur J Clin Nutr (2003) 0.88
Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. Cornea (1995) 0.87
Prevention of allergic eye disease by treatment with IL-1 receptor antagonist. Invest Ophthalmol Vis Sci (1999) 0.87
[A case of cerebral cryptococcosis, with special reference to computerized tomography findings]. No Shinkei Geka (1984) 0.86
Gender- and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice. J Steroid Biochem Mol Biol (1999) 0.86
Significance of Q wave disappearance in the chronic phase following transmural acute myocardial infarction. Jpn Circ J (1990) 0.86
Economic and quality of life impact of dry eye symptoms in women with Sjögren's syndrome. Adv Exp Med Biol (2002) 0.86
Differential chemokine gene expression in corneal transplant rejection. Invest Ophthalmol Vis Sci (1999) 0.85
Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation. Invest Ophthalmol Vis Sci (2000) 0.85
Phacoemulsification in patients after allogeneic bone marrow transplantation. Ophthalmology (2001) 0.85
Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants. Arch Ophthalmol (2000) 0.85
Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography. Hypertension (1999) 0.85
Identification and hormonal control of sex steroid receptors in the eye. Adv Exp Med Biol (1998) 0.84
Role of tumor necrosis factor receptors TNFR-I (P55) and TNFR-II (P75) in corneal transplantation. Transplantation (1999) 0.84
Differences in expression of sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger genes between adjacent and remote noninfarcted myocardium after myocardial infarction. J Mol Cell Cardiol (1997) 0.84
Corneal transplantation in young children with congenital hereditary endothelial dystrophy. Multicenter Pediatric Keratoplasty Study. Am J Ophthalmol (1999) 0.84
Molecular mechanisms of immunity in corneal allotransplantation and xenotransplantation. Expert Rev Mol Med (2001) 0.84
Intracranial chondroma. Surg Neurol (1977) 0.83
Reduction of subepithelial haze after photorefractive keratectomy by cooling the cornea. Am J Ophthalmol (1993) 0.83
Left ventricular filling determined by Doppler echocardiography in diabetes mellitus. Am J Cardiol (1988) 0.83
Influence of gender, sex steroid hormones, and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. Adv Exp Med Biol (1998) 0.83
Androgen regulation of the meibomian gland. Adv Exp Med Biol (1998) 0.83
[Angiogenesis and lymphangiogenesis in the cornea. Pathogenesis, clinical implications and treatment options]. Ophthalmologe (2003) 0.82
Corneal topography after selective suture removal for astigmatism following keratoplasty. Ophthalmic Surg Lasers (1997) 0.82
Expression of transcripts for cysteine-rich secretory proteins (CRISPs) in the murine lacrimal gland. J Cell Physiol (1999) 0.82
Increased comfort and decreased inflammation of the eye by cooling after cataract surgery. Am J Ophthalmol (1995) 0.82
Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjögren's syndrome. Adv Exp Med Biol (1998) 0.81
Corneal transplantation in antibody-deficient hosts. Invest Ophthalmol Vis Sci (1999) 0.81
Quantitative evaluation of postsurgical inflammation by infrared radiation thermometer and laser flare-cell meter. J Cataract Refract Surg (1994) 0.81
Estrogen and progesterone effects on the morphology of the mouse meibomian gland. Adv Exp Med Biol (2002) 0.81
A case of dobutamine-induced coronary arterial spasm with ST-segment elevation. Jpn Circ J (1998) 0.81
Plasma levels of platelet-derived growth factor in normal subjects and patients with ischemic heart disease. Am Heart J (1991) 0.80
Acute haemodynamic benefits of biatrial atrioventricular sequential pacing: comparison with single atrial atrioventricular sequential pacing. Heart (2004) 0.80
Prognostic value of Doppler transmittal flow patterns and cardiac natriuretic peptides in patients with chronic congestive heart failure admitted for episodes of acute decompensation. Heart Vessels (2000) 0.80
Extended wear soft contact lenses induce corneal epithelial changes. Br J Ophthalmol (1994) 0.79